Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Noninterventional

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Research Network

Common Treatments

  • Noninterventional1
  • Noninterventional Followup1

Active Sponsors

  • National Cancer Institute (NCI)1
  • AIDS Malignancy Consortium1

Top Investigators

Related Conditions

  • Aidsrelated Malignancy1
  • Hpvrelated Malignancy1
  • Anal Cancer1
  • Aidsrelated Kaposi Sarcoma1
  • Cancer1

Activity Timeline